Is sarcopenia associated with an increased risk of all-cause mortality and functional disability?
- PMID: 28647519
- PMCID: PMC5551458
- DOI: 10.1016/j.exger.2017.06.008
Is sarcopenia associated with an increased risk of all-cause mortality and functional disability?
Abstract
Background: While a recent meta-analysis of observational studies reported a statistically significant association between sarcopenia and both all-cause mortality and functional decline, a recently developed inverse heterogeneity (IVhet) model has been shown to be more valid than the traditional random-effects model used.
Objective: The objective of this short report was to use a previous meta-analysis to compare the two approaches.
Methods: Aggregate data meta-analysis of prospective observational studies conducted in any setting. Men and women 60years of age and older in which all-cause mortality (12 studies, 14,169 participants) or functional decline (6 studies, 8561 participants) was assessed. Using the IVhet model, pooling of previous studies regarding the association between sarcopenia and all-cause mortality as well as functional decline. Absolute and relative differences between IVhet and random-effects results were also calculated as well as influence analysis with each study deleted once. Non-overlapping 95% confidence intervals (CI) for odds ratios (OR) were considered statistically significant.
Results: Sarcopenia was associated with an increased risk for all-cause mortality (OR=3.64, 95% CI=2.94 to 4.51) and functional decline (OR=2.58, 95% CI=1.33 to 4.99). Compared to the random-effects model, the OR was slightly higher (0.04 or 1.1%) but with wider CI (0.16 or 11.3%) for all-cause mortality and 0.45 (14.9%) lower with a CI that was 0.34 (10.2%) wider for functional decline. With each study deleted from the model once, results remained statistically significant for both all-cause mortality and functional decline.
Conclusion: These results provide additional and more accurate evidence in support of an association between sarcopenia and an increased risk for both all-cause mortality and functional decline.
Keywords: Aging; IVhet model; Meta-analysis; Mortality; Sarcopenia.
Copyright © 2017 Elsevier Inc. All rights reserved.
Figures


Similar articles
-
Aerobic Exercise and Cancer-Related Fatigue in Adults: A Reexamination Using the IVhet Model for Meta-analysis.Cancer Epidemiol Biomarkers Prev. 2017 Feb;26(2):281-283. doi: 10.1158/1055-9965.EPI-16-0885. Epub 2016 Dec 1. Cancer Epidemiol Biomarkers Prev. 2017. PMID: 27908923 Free PMC article.
-
Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study.Age Ageing. 2013 Mar;42(2):203-9. doi: 10.1093/ageing/afs194. Epub 2013 Jan 15. Age Ageing. 2013. PMID: 23321202
-
Sarcopenia as a predictor of all-cause mortality among older nursing home residents: a systematic review and meta-analysis.BMJ Open. 2018 Nov 12;8(11):e021252. doi: 10.1136/bmjopen-2017-021252. BMJ Open. 2018. PMID: 30420343 Free PMC article.
-
Sarcopenia Is Associated With Incident Disability, Institutionalization, and Mortality in Community-Dwelling Older Men: The Concord Health and Ageing in Men Project.J Am Med Dir Assoc. 2015 Jul 1;16(7):607-13. doi: 10.1016/j.jamda.2015.02.006. Epub 2015 Mar 26. J Am Med Dir Assoc. 2015. PMID: 25820131
-
Consequences of sarcopenia.Clin Geriatr Med. 2011 Aug;27(3):387-99. doi: 10.1016/j.cger.2011.03.006. Epub 2011 May 14. Clin Geriatr Med. 2011. PMID: 21824554 Review.
Cited by
-
Adverse body measurements are superior to sarcopenia-associated measurements in predicting chronic diseases.Sci Rep. 2021 Apr 8;11(1):7749. doi: 10.1038/s41598-021-85316-0. Sci Rep. 2021. PMID: 33833267 Free PMC article.
-
Sarcopenia influences usage of reperfusion treatment in patients with pulmonary embolism aged 75 years and older.Int J Cardiol Heart Vasc. 2024 Jul 19;53:101470. doi: 10.1016/j.ijcha.2024.101470. eCollection 2024 Aug. Int J Cardiol Heart Vasc. 2024. PMID: 39132305 Free PMC article.
-
Sarcopenia as a mortality predictor in community-dwelling older adults: a comparison of the diagnostic criteria of the European Working Group on Sarcopenia in Older People.Eur J Clin Nutr. 2020 Apr;74(4):573-580. doi: 10.1038/s41430-019-0508-8. Epub 2019 Oct 4. Eur J Clin Nutr. 2020. PMID: 31586126
-
Gut microbial composition is altered in sarcopenia: A systematic review and meta-analysis of clinical studies.PLoS One. 2024 Aug 6;19(8):e0308360. doi: 10.1371/journal.pone.0308360. eCollection 2024. PLoS One. 2024. PMID: 39106230 Free PMC article.
-
Association of sarcopenia with basic activities of daily living and dyspnea-related limitations in patients with interstitial lung disease.J Thorac Dis. 2025 Feb 28;17(2):564-575. doi: 10.21037/jtd-24-1631. Epub 2025 Feb 24. J Thorac Dis. 2025. PMID: 40083499 Free PMC article.
References
-
- Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52:80–85. - PubMed
-
- United Nations, Department of Economic and Social Affairs, Population Division. World Population Ageing. 2015. 2015
-
- Dersimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical